U.S. Centers for Disease Control and Prevention
Alexander Fleming developed penicillin, the first antibiotic, in 1928. In less than a century, scientists have developed more than 130 other antibiotics — saving millions of lives, making surgery safer than ever, transforming medicine … and creating the huge new problem of antibiotic resistance that threatens to toss us back into the pre-antibiotic era.
Take gonorrhea for just one example: humans have gone from having no way to treat the disease in the 1920s to having effective antibiotics against it to now, when the “bacteria has developed resistance to nearly every drug used for treatment,” according to the CDC. Continue reading
Looking for a local angle to cover antibiotic resistance?
Reporters can find potential stories by looking at the Centers for Disease Control and Prevention’s newly released antibiotic resistance investment map which provides details on superbug cases in states and CDC efforts to contain their spread. Continue reading
Potentially deadly Clostridium difficile (C. diff), which sickened an estimated half million Americans one recent year, has gained notoriety as a hospital-acquired infection.
Patients who have taken antibiotics face an elevated risk of acquiring the diarrheal disease, and the majority of infections occur in health care facilities, research has shown. Continue reading
A report released by the U.S. Food and Drug Administration showed that an increasing number of Americans infected with the foodborne pathogen, salmonella, are resistant to multiple antibiotics.
In 2015, multidrug resistance rose to 12 percent of salmonella cases, from 9 percent the year before, the FDA said. Eating raw or undercooked meat, poultry or egg products can cause salmonella infection. Continue reading
The rise of deadly, drug-resistant superbugs is one of the world’s most pressing public health concerns. The dangerous development is driven by overuse and misuse of antibiotics in medicine and agriculture, resulting in a dramatic increase in people infected with antibiotic-resistant bacteria.
By 2050, 10 million people globally could die from drug-resistant bugs, which could lead to a loss of productivity of $100 trillion. Continue reading